Stocks · Healthcare · Drug Manufacturers - General
Pfizer Inc. PFE
$27.80 -1.14% Close, Oct 2, 2026 · NYSE · Market cap $158.44B
High qualityLow risk
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 14 quarters (average surprise over the last four: +17.7%).
- Diluted EPS over the last four quarters was $0.76, down 59.9% year over year.
- The shares trade at 36.7× trailing earnings, higher than 89% of the company's own readings over the past five years.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth11Very weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 30%
- EPS growth (TTM, YoY)Bottom 27%
- FCF growth (TTM, YoY)Bottom 30%
- Revenue growth, 3-year CAGRBottom 10%
- Revenue growth accelerationBottom 37%
Quality87Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 15%
- Gross marginTop 41%
- Operating marginTop 10%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Bottom 39%
- Net debt / EBITDA (lower is better)Bottom 14%
- Interest coverTop 23%
Value71Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 20%
- Free-cash-flow yieldTop 13%
- EBITDA / enterprise valueTop 20%
- Sales / enterprise valueTop 43%
- P/E vs own 5-year history (lower is better)Bottom 13%
Momentum61Neutral
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 39%
- 6-month returnBottom 41%
- 1-year return vs S&P 500Bottom 44%
- Distance from 52-week highTop 5%
- Trend checklist (0–4)Top 20%
Revisions45Neutral
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 27%
- Consecutive EPS beatsTop 2%
- Share of analysts rating BuyBottom 7%
- Upside to consensus price targetBottom 12%
Stability84Strong
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 1%
- Maximum drawdown, 3 yearsTop 10%
- Beta vs S&P 500 (lower is better)Top 14%
- Net debt / EBITDA (lower is better)Bottom 14%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 1.4% | -0.2% | ↓ |
| EPS growth (YoY) | -5.1% | -59.9% | ↓ |
| Gross margin | 67.3% | 71.3% | ↑ |
| Operating margin | 29.6% | 25.1% | ↓ |
| FCF margin | 19.5% | 17.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -0.2% | 1.4% | ↓ | Bottom 30% |
| EPS growth (TTM, YoY) | -59.9% | -5.1% | ↓ | Bottom 27% |
| Gross margin | 71.3% | 67.3% | ↑ | Top 41% |
| Operating margin | 25.1% | 29.6% | ↓ | Top 10% |
| Net margin | 6.8% | 16.8% | ↓ | — |
| Free-cash-flow margin | 17.2% | 19.5% | ↓ | — |
| Return on invested capital | 9.3% | — | Top 15% | |
| Revenue growth, 3-year CAGR | -14.6% | — | Bottom 10% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -22.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.93×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 5.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 6.18%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 6.18%
- Share count change, 1 year
- -0.1%
- Share count change, 3-year CAGR
- -0.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 28, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 14
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +17.7%
- Average 2-day reaction, last 8
- +0.4%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $28.50
- Target vs current price
- +2.5%
- Analysts with a rating
- 39
- Share rating Buy or Strong Buy
- 38%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +12.9% | +1.5% | +8.1% | +13.7% | — |
| May 5, 2026 | +3.9% | +0.6% | -1.9% | -2.9% | -5.3% |
| Feb 3, 2026 | +16.4% | -3.3% | +1.5% | -0.3% | -1.5% |
| Nov 4, 2025 | +37.4% | -1.5% | -1.1% | +2.0% | +7.2% |
| Aug 5, 2025 | +34.5% | +5.2% | +4.5% | +6.2% | +4.1% |
| Apr 29, 2025 | +38.1% | +3.2% | +3.6% | +2.4% | +10.0% |
| Feb 4, 2025 | +33.6% | -1.3% | -1.3% | -1.7% | -6.8% |
| Oct 29, 2024 | +72.6% | -1.4% | -3.8% | -9.3% | -6.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.77 | $0.68 | +12.9% | $15.03B |
| May 5, 2026 | $0.75 | $0.72 | +3.9% | $14.45B |
| Feb 3, 2026 | $0.66 | $0.57 | +16.4% | $17.56B |
| Nov 4, 2025 | $0.87 | $0.63 | +37.4% | $16.65B |
| Aug 5, 2025 | $0.78 | $0.58 | +34.5% | $14.65B |
| Apr 29, 2025 | $0.92 | $0.67 | +38.1% | $13.71B |
| Feb 4, 2025 | $0.63 | $0.47 | +33.6% | $17.76B |
| Oct 29, 2024 | $1.06 | $0.61 | +72.6% | $17.70B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 36.7× | 14.4× | 89th | Top 20% |
| P/E (forward) | 9.3× | — | — | — |
| EV / EBITDA | 17.5× | — | — | Top 20% |
| EV / Sales | 3.46× | — | — | Top 43% |
| Free-cash-flow yield | 6.93% | — | — | Top 13% |
| Earnings yield | 2.72% | — | — | Top 20% |
P/E over the past five years
Range 7.5× – 77.7× since Jul 4, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +2.2%
- Earnings per share growth (TTM)
- -59.9%
- Change in P/E multiple
- +155.8%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 43
- Days above the 200-day average
- 41
- 50-day average slope (20 days)
- +5.6%
- 200-day average slope (20 days)
- +1.0%
- Distance from 50-day average
- +1.7%
- Distance from 200-day average
- +5.3%
- RSI (14)
- 47.7
- Relative volume
- 1.09×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 19.2%
- Volatility vs own 5-year history
- 5th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.47
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -4.2%
- Maximum drawdown, 3 years
- -36.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 16, 2021 | Apr 10, 2025 | -64.8% | 831 days | Not yet recovered |
| Dec 8, 2020 | Feb 26, 2021 | -21.3% | 54 days | 105 days (Jul 28, 2021) |
| Aug 17, 2021 | Oct 18, 2021 | -18.1% | 43 days | 22 days (Nov 17, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $158.44B
- P/E (TTM)
- 36.7
- EPS, diluted (TTM)
- $0.76
- Revenue (TTM)
- $63.70B
- Dividend yield
- 6.19%
- 52-week range
- $23.62 – $29.21
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $81.29B | $100.33B | $59.55B | $63.63B | $62.58B |
| Gross profit | $46.88B | $62.09B | $30.34B | $41.85B | $44.01B |
| Operating income | $20.79B | $37.55B | $5.29B | $16.48B | $15.44B |
| Net income | $22.15B | $31.36B | $2.13B | $8.02B | $7.77B |
| EPS (diluted) | $3.88 | $5.47 | $0.37 | $1.41 | $1.36 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.70B | $17.76B | $13.71B | $14.65B | $16.65B | $17.56B | $14.45B | $15.03B |
| Net income | $4.47B | $403.0M | $2.97B | $2.91B | $3.54B | -$1.65B | $2.69B | -$246.0M |
| EPS (diluted) | $0.78 | $0.07 | $0.52 | $0.51 | $0.62 | -$0.29 | $0.47 | -$0.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $32.58B | $29.27B | $8.70B | $12.74B | $11.71B |
| Capital expenditure | -$2.71B | -$3.24B | -$3.91B | -$2.91B | -$2.63B |
| Free cash flow | $29.87B | $26.03B | $4.79B | $9.84B | $9.08B |
| Dividends paid | -$8.73B | -$8.98B | -$9.25B | -$9.51B | -$9.77B |
| Net share buybacks | $0 | -$2.00B | $0 | $0 | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $11.70B
- Total assets
- $201.13B
- Total liabilities
- $115.64B
- Total debt
- $63.19B
- Net debt
- $62.22B
- Shareholders’ equity
- $85.19B
As of Jun 28, 2026 (filed Aug 4, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Jul 24, 2026 | $0.43 | Sep 1, 2026 |
| May 8, 2026 | $0.43 | Jun 12, 2026 |
| Jan 23, 2026 | $0.43 | Mar 6, 2026 |
| Nov 7, 2025 | $0.43 | Dec 1, 2025 |
| Jul 25, 2025 | $0.43 | Sep 2, 2025 |
| May 9, 2025 | $0.43 | Jun 13, 2025 |
| Jan 24, 2025 | $0.43 | Mar 7, 2025 |
| Nov 8, 2024 | $0.42 | Dec 2, 2024 |
Short interest
- Shares sold short
- 155,202,257
- Days to cover
- 4.90
- Change vs previous report
- +2.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 17, 2020
- 527-for-500
- Jul 1, 1999
- 3-for-1
- Jul 1, 1997
- 2-for-1
- Jul 3, 1995
- 2-for-1
- Apr 1, 1991
- 2-for-1